Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

5.1%

6 terminated/withdrawn out of 117 trials

Success Rate

93.1%

+6.6% vs industry average

Late-Stage Pipeline

14%

16 trials in Phase 3/4

Results Transparency

1 of 81 completed trials have results

Key Signals

5 recruiting1 with results6 terminated

Enrollment Performance

Analytics

N/A

53(62.4%)

Phase 2

10(11.8%)

Phase 4

9(10.6%)

Phase 3

7(8.2%)

Phase 1

3(3.5%)

Early Phase 1

3(3.5%)

85Total

N/A(53)

Phase 2(10)

Phase 4(9)

Phase 3(7)

+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (117)

Showing 20 of 117 trials

NCT07570901Completed

Impact of Delta Model of End Stage Liver Disease (MELD) in High MELD Liver Transplant Recipients

Role: lead

NCT02083835Recruiting

PAIN OUT: Improvement in Postoperative PAIN OUTcome

Role: lead

NCT04975594Active Not Recruiting

Statin-Intolerance Registry

Role: collaborator

NCT07250919Completed

Donor and Recipient Mismatch in Liver Transplantation

Role: lead

NCT07189481Completed

Design and Evaluation of a Team Timeout Checklist (TTOC) to Improve Information Exchange in the Operating Room Before Skin Incision

Role: lead

NCT05814874Not ApplicableCompleted

Improvement of the Selenium Supply in a Vegan Diet by Different Selenium Sources

Role: lead

NCT03906292Phase 2Active Not Recruiting

Frontline Asciminib Combination in Chronic Phase CML

Role: lead

NCT05392283Not ApplicableCompleted

Vacuum Cupping for Chronic Neck and Back Pain

Role: collaborator

NCT06323538Recruiting

Cohort Study on Plant-based Diets (COPLANT Study)

Role: collaborator

NCT06137378Phase 2Recruiting

European Larynx Organ Preservation Study (ELOS) [MK-3475-C44]

Role: collaborator

NCT03582020Not ApplicableCompleted

Nutritional Evaluation - NuEva Study

Role: lead

NCT06251349Completed

Comparative Analysis of Radiotherapeutic and Medical Procedures for the Prophylaxis of Heterotopic Ossifications

Role: lead

NCT04902937Recruiting

Association of Adjuvant Radiotherapy of Non-metastatic Breast Carcinoma With Immunomodulation and Circulating Tumor Cell Phenotype in Relation to Patient Age.

Role: lead

NCT03869502Unknown

European CML Blast Crisis Register

Role: lead

NCT03933852Unknown

Observational Study on Chronic Myeloid Leukemia Patients in Any Phase Treated With Ponatinib (Iclusig®) at Any Dose

Role: lead

NCT02890784Phase 3Completed

Dasatinib Holiday for Improved Tolerability

Role: lead

NCT01657604Phase 3Completed

TKI and Interferon Alpha Evaluation Initiated by the German Chronic Myeloid Leukemia Study Group - the TIGER Study

Role: lead

NCT03052283Recruiting

Development and Validation of a Disease Specific PROM to Assess Abdominal Involvement in Patients With CF (CFAbd-Score)

Role: collaborator

NCT04001244Completed

Translational Research in Pelvic Pain

Role: collaborator

NCT02637778Not ApplicableCompleted

Modulation of Cardiovascular Risk Factors by the Diet

Role: lead